Cytek Biosciences
CTKB
CTKB
101 hedge funds and large institutions have $658M invested in Cytek Biosciences in 2023 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 18 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
1% less funds holding
Funds holding: 102 → 101 (-1)
4% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 25
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
101
Holding in Top 10
–
Calls
$1.51M
Puts
$36K
Top Buyers
| 1 | +$58.4M | |
| 2 | +$23.3M | |
| 3 | +$18.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$11.5M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$3.7M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$10.2M | |
| 3 | -$9.25M | |
| 4 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$8.94M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$5.34M |